Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
My View
Tags:
Consumer OTC Drugs

Bayer Focuses On OTCs As Consumer Care Streamlining Continues

This article was originally published in The Tan Sheet

  • News
  • The Tan Sheet

Executive Summary

Bayer AG reaffirmed its commitment to its nonprescription products portfolio as the firm continues to streamline its consumer care division

You may also be interested in...



Bayer Shuffle To Result In Increased Consumer Care Focus

Bayer expects the establishment of its healthcare operations as a separate business unit will allow an increased focus on its consumer care business, CEO Werner Wenning said in a Nov. 11 earnings call

Bayer Shuffle To Result In Increased Consumer Care Focus

Bayer expects the establishment of its healthcare operations as a separate business unit will allow an increased focus on its consumer care business, CEO Werner Wenning said in a Nov. 11 earnings call

Bayer Shuffle To Result In Increased Consumer Care Focus

Bayer expects the establishment of its healthcare operations as a separate business unit will allow an increased focus on its consumer care business, CEO Werner Wenning said in a Nov. 11 earnings call

Table

View full table

Topics

Tags:
Consumer OTC Drugs
Latest Headlines

Generic Or Innovator? Sandoz Sues CMS Over Potential Change In Rebate Classification

US FDA Gene Therapy Accelerated Approval Guidance Will Describe ‘Buckets’ Of Use Scenarios

FTC Early Findings In PBM Investigation Coming By Mid-Summer, Chair Kahn Says

New EU Filings

See All
UsernamePublicRestriction

Register

PS094781

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By